Streptozocin
(Synonyms: 链脲佐菌素; Streptozotocin; U 9889) 目录号 : GC17131
Streptozocin 是一种有效的 DNA 甲基化抗生素，是一种天然存在的亚硝基酰胺，在实验模型中广泛用于产生糖尿病。
Cas No.:18883-66-4
Sample solution is provided at 25 µL, 10mM.
Streptozocin, a potent DNA-methylating antibiotic, is a naturally occurring nitrosoamide used for extensively to produce diabetes in experimental models.[1]
In vitro, STZ was toxic with IC50 values of 11.7, 904 and 1024 μg/ml for HL60, K562 and C1498 cells respectively.[3]
In vivo efficacy test it shown that when combined with a protocol for induction of diuresis, dogs were treated safely with 500 mg/m2 of streptozocin, intravenously, every 3 weeks, and it may be have a potential efficacy on the treatment of dogs with metastatic pancreatic islet cell tumors.[1]
In vivo experiment it indicated that mice were administrated streptozocin with 65 mg/kg intraperitoneally for 8-11 days or 14-17 days, streptozocin improved the impaired development of preimplantation embryos on 8-11 days. However, after 14-17 days, the incidence of degenerated embryos was increased in both streptozocin-treated mice groups.[2] Treatment with 60 mg/kg of streptozocin intravenously also induces an early hyperglycaemia when the hepatic glycogen storage is almost depleted that is during the fasting state.[4] For the treatment of advanced islet-cell carcinoma, the combination of streptozocin and doxorubicin is more efficious than the current standard regimen of streptozocin plus fluorouracil.[5] There is little value for patients with malignant carcinoid tumors by combination treatment with streptozocin and 5-fluorouracil.[6]
References:
[1].Moore AS, et al. Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989-1999). J Am Vet Med Assoc. 2002 Sep 15;221(6):811-8.
[2].Veselá J, et al. Subdiabetogenic streptozocin treatment impairs preimplantation development of mouse embryos. Physiol Res. 1993;42(1):23-7.
[3].Diab RA, et al. Immunotoxicological effects of streptozotocin and alloxan: in vitro and in vivo studies. Immunol Lett. 2015 Feb;163(2):193-8.
[4].Wong KK. Reduction by streptozocin of blood glucose utilization during the appearance of the streptozocin induced early hyperglycaemia in fasting rats. Biochem Mol Biol Int. 1996 May;39(1):191-5.
[5].Moertel CG, et al. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1992 Feb 20;326(8):519-23.
[6].Oberg K, et al. Cytotoxic treatment in patients with malignant carcinoid tumors. Response to streptozocin--alone or in combination with 5-FU. Acta Oncol. 1987;26(6):429-32.
Streptozocin 是一种有效的 DNA 甲基化抗生素，是一种天然存在的亚硝基酰胺，在实验模型中广泛用于产生糖尿病。[1]
在体外，STZ 对 HL60、K562 和 C1498 细胞的 IC50 值分别为 11.7、904 和 1024 μg/ml。[3]
体内功效测试表明，当与诱导利尿方案相结合时，狗可以安全地每 3 周静脉注射 500 mg/m2 链佐星，并且它可能对治疗患有转移性胰岛细胞瘤的狗。[1]
体内实验表明，给小鼠腹腔注射65 mg/kg链脲佐菌素8-11天或14-17天，链脲佐菌素在8-11天改善着床前胚胎发育受损。然而，在 14-17 天后，两个接受链脲佐菌素治疗的小鼠组的退化胚胎发生率都增加了。[2] 静脉注射 60 mg/kg 链佐佐星也可诱导早期高血糖症，此时肝糖原储存在禁食状态下几乎耗尽。[4]对于晚期胰岛细胞癌的治疗，链佐星和多柔比星的组合比目前链佐星加氟尿嘧啶的标准方案更有效.[5]链脲佐菌素与5-氟尿嘧啶联合治疗恶性类癌患者价值不大。[6]
| Cell experiment [1]: | |
|
Cell lines |
islet cells |
|
Preparation Method |
Monolayer cultures of islet cells from neonatal rats were exposed to concentrations of MNU and STZ (Streptozocin) of 1, 2, 5, or 10 mM, and the activity of the enzyme was assayed. |
|
Reaction Conditions |
1, 2, 5, or 10 mM |
|
Applications |
Streptozocin is toxic to cultured p-cells at a concentration of 1 mM. |
| Animal experiment [2]: | |
|
Animal models |
Female mice |
|
Preparation Method |
Female mice received a single subdiabetogenic dose of streptozocin (65 mg/kg intraperitoneally) 8-11 days or 14-17 days before fertilization. |
|
Dosage form |
65 mg/kg; i.p. |
|
Applications |
Morphological analysis of preimplantation embryos collected on day 3 of pregnancy revealed significant changes in the distribution pattern of preimplantation embryo stages recovered from streptozocin-treated females. |
|
References: [1]. Wilson GL, et al. Mechanisms of nitrosourea-induced beta-cell damage. Activation of poly (ADP-ribose) synthetase and cellular distribution. Diabetes. 1988 Feb;37(2):213-6. [2]. Veselá J, et al. Subdiabetogenic streptozocin treatment impairs preimplantation development of mouse embryos. Physiol Res. 1993;42(1):23-7. |
|
| Cas No. | 18883-66-4 | SDF | |
| 别名 | 链脲佐菌素; Streptozotocin; U 9889 | ||
| 化学名 | 1-methyl-1-nitroso-3-[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea | ||
| Canonical SMILES | CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O | ||
| 分子式 | C8H15N3O7 | 分子量 | 265.22 |
| 溶解度 | ≥ 10.3mg/mL in DMSO, ≥ 53.2mg/mL in Water, ≥ 26.5mg/mL in EtOH with gentle warming | 储存条件 | -20°C, protect from light, stored under nitrogen,unstable in solution, ready to use. |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.7705 mL | 18.8523 mL | 37.7045 mL |
| 5 mM | 0.7541 mL | 3.7705 mL | 7.5409 mL |
| 10 mM | 0.377 mL | 1.8852 mL | 3.7705 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet